← Open Payments lookup

DEWNZAR HOWARD: Open Payments

NPI 1912016759 · DYER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$663 in 28 payments from 10 companies in 2025. Trend: 2023 $66 · 2024 $239 · 2025 $663

Food & beverage: $552Education: $111
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.7$212
Vanda Pharmaceuticals Inc.5$93
Otsuka America Pharmaceutical, Inc.3$71
E.R. Squibb & Sons, L.L.C.3$63
Axsome Therapeutics, Inc.2$59
Lundbeck LLC2$46
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$41
Noven Therapeutics, LLC2$37
Neurocrine BioSciences, Inc.1$23
Janssen Pharmaceuticals, Inc1$18

Products named: FANAPT, REXULTI, COBENFY, UZEDY, Auvelity, ABILIFY MAINTENA, CAPLYTA, AUSTEDO XR.

Industry payments across IN — which companies pay providers there.